169 related articles for article (PubMed ID: 21466823)
1. Towards the design of combination therapy for the treatment of enterovirus infections.
Thibaut HJ; Leyssen P; Puerstinger G; Muigg A; Neyts J; De Palma AM
Antiviral Res; 2011 Jun; 90(3):213-7. PubMed ID: 21466823
[TBL] [Abstract][Full Text] [Related]
2. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
3. Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.
Wildenbeest JG; van den Broek PJ; Benschop KS; Koen G; Wierenga PC; Vossen AC; Kuijpers TW; Wolthers KC
Antivir Ther; 2012; 17(3):459-66. PubMed ID: 22293148
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.
Zhang G; Zhou F; Gu B; Ding C; Feng D; Xie F; Wang J; Zhang C; Cao Q; Deng Y; Hu W; Yao K
Arch Virol; 2012 Apr; 157(4):669-79. PubMed ID: 22245989
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo.
Yang Y; Zhang L; Fan X; Qin C; Liu J
Bioorg Med Chem Lett; 2012 Mar; 22(6):2209-11. PubMed ID: 22342145
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses.
Kang H; Kim C; Kim DE; Song JH; Choi M; Choi K; Kang M; Lee K; Kim HS; Shin JS; Kim J; Han SB; Lee MY; Lee SU; Lee CK; Kim M; Ko HJ; van Kuppeveld FJ; Cho S
Antiviral Res; 2015 Dec; 124():1-10. PubMed ID: 26526589
[TBL] [Abstract][Full Text] [Related]
7. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
Tonew M; Tonew E; Oehring H; Schmidt J
Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo.
Yang Y; Xiu J; Zhang L; Qin C; Liu J
Phytomedicine; 2012 Dec; 20(1):67-70. PubMed ID: 23146421
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-enterovirus activity of new analogues of MDL-860.
Dobrikov GM; Slavchev I; Nikolova I; Stoyanova A; Nikolova N; Mukova L; Nikolova R; Shivachev B; Galabov AS
Bioorg Med Chem Lett; 2017 Oct; 27(19):4540-4543. PubMed ID: 28870395
[TBL] [Abstract][Full Text] [Related]
10. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
12. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
13. Antiviral activity of naphthoquinones. I. Lapachol derivatives against enteroviruses.
Pinto AV; Pinto Mde C; Lagrota MH; Wigg MD; Aguiar AN
Rev Latinoam Microbiol; 1987; 29(1):15-20. PubMed ID: 2820010
[No Abstract] [Full Text] [Related]
14. Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones.
Kumar Biswas B; Malpani YR; Ha N; Kwon DH; Soo Shin J; Kim HS; Kim C; Bong Han S; Lee CK; Jung YS
Bioorg Med Chem Lett; 2017 Aug; 27(15):3582-3585. PubMed ID: 28587824
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.
Galabov AS; Nikolova I; Vassileva-Pencheva R; Stoyanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):91-9. PubMed ID: 27442375
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Efficacy of Antiviral Compounds against Enterovirus D68.
Rhoden E; Zhang M; Nix WA; Oberste MS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7779-81. PubMed ID: 26149998
[TBL] [Abstract][Full Text] [Related]
17. Special Issue "Enteroviruses 2021".
Ho HY
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215899
[TBL] [Abstract][Full Text] [Related]
18. [In vitro study on the effect of ribavirin reducing the EV71 replication].
Zhang Y; Zhu Z; Zhu SL; An HQ; Yang ZH; Guo XB; Xu WB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):44-6. PubMed ID: 19799016
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
